Recent Articles from GlobeNewswire

Northland Power Reports Third Quarter 2026 Results, Value Accretive Growth Updates and Reaffirms 2026 Guidance
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and nine months ended September 30, 2026. All dollar amounts set out herein are in Canadian dollars, unless otherwise stated.
By Northland Power Inc. · Via GlobeNewswire · November 12, 2026
Silver Market Set for Sixth Consecutive Annual Deficit in 2026
Industrial Silver Demand Outside Photovoltaics Forecast to Grow by 4.5%
By The Silver Institute · Via GlobeNewswire · November 12, 2026
Intermap Announces Date for Third Quarter 2026 Financial Results
DENVER, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in geospatial intelligence powered by proprietary 3D data, rapid image processing software and AI-driven analytics, today announced that it will release its third quarter 2026 financial results after market close on November 16, 2026. Intermap’s CEO Patrick A. Blott and CFO Jennifer Bakken will host a live webcast the same day at 5:00 pm ET to review the Company’s financial results and answer investor questions following the presentation.
By Intermap Technologies · Via GlobeNewswire · November 12, 2026
Cellectis Reports Third Quarter 2026 Financial Results and Provides a Business Update
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, today reported financial results for the third quarter 2026 ended September 30, 2026, and provided a business update.
By Cellectis Inc. · Via GlobeNewswire · November 12, 2026
Windward Bio Announces Pricing of Initial Public Offering
BASEL, Switzerland, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG (“Windward”) (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, today announced the pricing of its initial public offering of 10,294,117 common shares at a public offering price of $17.00 per share. In addition, Windward has granted the underwriters a 30-day option to purchase up to an additional 1,544,117 common shares at the initial public offering price, less the underwriting discounts and commissions. The gross proceeds to Windward from the initial public offering and the concurrent private placement (see below), without giving effect to the underwriters’ option to purchase additional shares and before deducting underwriting discounts and commissions and offering expenses, are expected to be $225.0 million. All of the common shares are being offered by Windward.
By Windward Bio Group AG · Via GlobeNewswire · November 12, 2026
Proficient Auto Logistics Reports Third Quarter 2026 Financial Results
JACKSONVILLE, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its financial results for the three months ended September 30, 2026.
By Proficient Auto Logistics, Inc. · Via GlobeNewswire · November 12, 2026
Book gifts: what readers want, what they spend and what actually gets read
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) What do readers want in a book gift? A title they asked for, a sign the giver was paying attention and, for many, a pre-owned copy they would welcome as much as a new one, according to an October 2026 survey commissioned by ThriftBooks.
By Feature Impact · Via GlobeNewswire · November 12, 2026
Xi'an Study Tour by International Think Tank, Media Experts Held to Promote Belt and Road Exchanges
The Belt and Road Forum for International Think Tank Cooperation 2026 & the 4th Silk Road (Xi'an) International Communication Forum
Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency
MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR), the leading super app providing financial and digital commerce services to over 46 million customers, today reported its results for the third quarter of 2026.
By Inter&Co, Inc · Via GlobeNewswire · November 12, 2026
After the Midterms, New Poll Finds Israeli-Palestinian Policy Factored into Half of Voters' Decisions — Including 63% of Younger Voters
New survey finds 89% consider a quick pivot toward Israeli-Palestinian peace negotiations important amid U.S. involvement with Iran, with cross-party support for peacebuilding, Gaza aid and action on West Bank settler violence.
By Alliance for Middle East Peace · Via GlobeNewswire · November 12, 2026
Rocket Lab To Launch Milestone 100th Electron Rocket This Week
Less than a decade after its debut, Electron is set to reach 100 launches faster than any other commercially developed rocket in history.
By Rocket Lab Corporation · Via GlobeNewswire · November 12, 2026
Mattr Announces Third Quarter 2026 Results: Sequential Growth Drives Record Third Quarter Revenue and Adjusted EBITDA
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three and nine months ended September 30, 2026. This press release should be read in conjunction with the Company’s Management's Discussion and Analysis (“MD&A”) and unaudited condensed interim consolidated financial statements for the three and nine months ended September 30, 2026, which are available on the "Investor Center" page of the Company’s website and at www.sedarplus.ca.
By Mattr Corp. · Via GlobeNewswire · November 12, 2026
Stantec reports third quarter 2026 results with strong net revenue growth and record adjusted EBITDA margin; raises profitability outlook
EDMONTON, Alberta and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Stantec (TSX, NYSE:STN), a global leader in sustainable engineering, architecture and environmental consulting, released its third quarter 2026 results today. In the third quarter, net revenue increased 9.4% year-over-year to $1.9 billion, driven by organic growth of 5.3% and acquisition growth1 of 2.6%. Third quarter 2026 adjusted EBITDA increased 16.6% or $53.7 million, and adjusted EBITDA margin reached 20.2%, up 120 basis points compared to the third quarter 2025. Stantec delivered diluted earnings per share (EPS) of $1.60 and adjusted EPS of $1.89.
By Stantec Inc. · Via GlobeNewswire · November 12, 2026
POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms
Data presented today for the first time at the American Autonomic Society (AAS) annual meeting
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · November 12, 2026
Aetherion™ Reports Third Quarter 2026 Financial Results
~ Strong demand for LNG HPDI™ trucks continues to drive revenue growth for Cespira™ ~
By Aetherion Technologies Canada Inc. · Via GlobeNewswire · November 12, 2026
Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026
SANTA MONICA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (Nasdaq: SLE) ("Super League" or the "Company"), an audience intelligence and media activation company trusted by global brands to reach and engage people who play video games, today announced that it will release its financial results for the third quarter ended September 30, 2026 after market close on Monday, November 16, 2026, at 5:00 p.m. Eastern Time.
By Super League Enterprise · Via GlobeNewswire · November 12, 2026
iAnthus Reports Fiscal Third Quarter 2026 Financial Results and Change in Auditor
NEW YORK and TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the third quarter ended September 30, 2026. The Company’s Quarterly Report on Form 10-Q (the “Quarterly Report”), which includes its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2026 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval's (SEDAR+) website at www.sedarplus.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.
By iAnthus Capital Holdings, Inc. · Via GlobeNewswire · November 12, 2026
Montauk Renewables Re-schedules Third Quarter 2026 Conference Call for Monday, November 16, 2026, at 8:30 a.m. ET
PITTSBURGH, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk” or “the Company") (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), has rescheduled its conference call and webcast for Monday, November 16, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2026. The Company expects to issue a press release reporting the financial results and file its Form 10-Q for its third quarter 2026 before the open of regular stock market trading hours on the same day as the conference call and webcast.
By Montauk Renewables · Via GlobeNewswire · November 12, 2026
Exco Technologies Limited Announces Fourth Quarter Results on December 2, 2026
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Exco Technologies Limited (TSX – XTC) today announced that it will report its financial results for the fourth quarter ended September 30, 2026 after the close of business on Wednesday December 2, 2026.
By Exco Technologies Ltd. · Via GlobeNewswire · November 12, 2026
SalesHood MCP Brings Trusted Revenue Enablement into the AI Tools Sales Teams Already Use
Revenue teams get questions answered, find approved content, create buyer-ready assets, and share them to their Digital Sales Rooms from Claude, ChatGPT, Gemini, Microsoft Copilot, Glean, Perplexity, or any AI tool that supports MCP
By SalesHood · Via GlobeNewswire · November 12, 2026
AirJoule Technologies Schedules Release of Third Quarter 2026 Results and Conference Call
RONAN, Mont., Nov. 12, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”) today announced that it will report its third quarter 2026 results before market open on Monday, November 16, 2026. Company management will host a conference call and Q&A session to discuss the results at 8:30 AM ET on the same day.
By AirJoule Technologies Corporation · Via GlobeNewswire · November 12, 2026
NAED Energy Holding Inc. Details the Rating of Its PV-1 Tandem Cell Line: 16,000 Wafers per Hour per Line, 4.6 GW from Six Lines
MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- NAED Energy Holding Inc. (NAED) today published the rating of PV-1, its production line for T2X perovskite/silicon heterojunction tandem solar cells. Each PV-1 line is rated at 16,000 G12 half-cut wafers per hour: 400 wafers every 90-second index, a rate set by the line’s inline PVD tool (ITO-1). The line’s four PECVD modules are built for a faster 76-second index, about 18,950 wafers per hour.
By NAED Energy Holding Inc · Via GlobeNewswire · November 12, 2026
BANK OF AMERICA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bank of America and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Bank of America (BAC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2026
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Planned global Phase 3 LEGACY trial of tegoprubart in kidney transplantation remains on track to initiate in Q4 2026
By Eledon Pharmaceuticals, Inc. · Via GlobeNewswire · November 12, 2026
3D Systems Celebrates 40 Years During Formnext 2026
ROCK HILL, S.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced plans to celebrate, at Formnext 2026, the 40th anniversary of the founding of 3D Systems and 43 years of the invention of SLA 3D printing by co-founder Chuck Hull. With guest appearances by Chuck Hull and opportunities to see and touch the original 3D-printed part, attendees can understand the origins of additive manufacturing, combined with 3D Systems’ vision of the future of manufacturing.
By 3D Systems Inc. · Via GlobeNewswire · November 12, 2026
ILLR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Triller Group Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Triller (ILLR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2026
D-WAVE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds D-Wave Quantum Inc. Investors with Large Losses to Contact the Firm Before December 14th Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In D-Wave (QBTS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2026
Gemini Reports Third Quarter 2026 Results
Total revenue of $40.9 million, with services revenue and interest income at 59% of net revenue as platform spot trading volume declined 73% year-over-year; total operating expenses decreased 30% year-over-year
By Gemini Space Station, Inc. · Via GlobeNewswire · November 12, 2026
Martinrea International Inc. Reports Third Quarter Results and Declares Dividend
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the third quarter ended September 30, 2026, and declared a quarterly cash dividend of $0.05 per share.
By Martinrea International Inc. · Via GlobeNewswire · November 12, 2026
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Submission is based on Phase 3 REZILIENT3 data in first-line EGFR ex20ins NSCLC
By Cullinan Therapeutics, Inc. · Via GlobeNewswire · November 12, 2026
Standard Lithium Reports Third Quarter 2026 Results
VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three- and nine-month periods ended September 30, 2026.
By Standard Lithium · Via GlobeNewswire · November 12, 2026
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Detailed launch readiness for relutrigine and ulixacaltamide, with PDUFA target action dates of December 27, 2026 and January 29, 2027
By Praxis Precision Medicines, Inc. · Via GlobeNewswire · November 12, 2026
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Continued Progress in Technology Readiness for AI Datacom Market
By Aeluma, Inc. · Via GlobeNewswire · November 12, 2026
Live Oak Bancshares, Inc. Closes Depositary Share Offering
WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the closing of its previously announced underwritten offering of 4,000,000 depositary shares, each representing a 1/40th interest in a share of its 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”), with a liquidation preference of $25 per depositary share. As a result of the public offering, Live Oak received proceeds of approximately $96,250,000, net of estimated expenses and underwriting discounts and commissions.
By Live Oak Bancshares, Inc. · Via GlobeNewswire · November 12, 2026
Robinhood Markets, Inc. Reports October 2026 Operating Data
MENLO PARK, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for October 2026.
By Robinhood Markets, Inc. · Via GlobeNewswire · November 12, 2026
Lulus Reports Third Quarter 2026 Results
CHICO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU) today reported financial results for the third quarter ended September 27, 2026, revised its financial outlook for the fiscal year ending January 3, 2027 and provided its financial outlook for the fiscal year ending January 2, 2028.
Future Technologies Expands Licensed Microwave Support to Help Cambium Legacy Customers Protect Network Investments
Expanded relationship with Ceragon Networks helps critical infrastructure operators evaluate options for maintaining network continuity and planning future modernization
By Future Technologies Venture, LLC · Via GlobeNewswire · November 12, 2026
CC INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Chemours (CC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2026
Xos Extends Gross Profit Streak, Highlighting Operational Efficiency
Recorded third consecutive quarter of positive GAAP gross profit: nine-month GAAP gross margin expanded to 26.9% from 13.3% in the prior year
By Xos, Inc. · Via GlobeNewswire · November 12, 2026
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
– Company reports record U.S. YCANTH net product revenue of $5.7 million in Q3 2026, up 11.9% over the previous quarter and 57.9% year-over-year, and total revenue of $6.9 million –
By Verrica Pharmaceuticals Inc. · Via GlobeNewswire · November 12, 2026
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 41,071,428 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 5,357,142 additional shares of its common stock, at a public offering price of $3.50 per share. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $143.7 million.
By Prime Medicine, Inc. · Via GlobeNewswire · November 12, 2026
John B. Sanfilippo & Son, Inc. Announces Share Repurchase Program and Special Dividend
Elgin, IL, Nov. 12, 2026 (GLOBE NEWSWIRE) --
By John B. Sanfilippo & Son, Inc. · Via GlobeNewswire · November 12, 2026
Innventure Reports Third Quarter 2026 Results
Company advances strategic repositioning through substantial cost reductions and disciplined capital allocation, with resources focused on preserving and maximizing the value of its interest in Accelsius
By Innventure, Inc. · Via GlobeNewswire · November 12, 2026
Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 11:30 a.m. GMT (6:30 a.m. ET).
By Enovis Corporation · Via GlobeNewswire · November 12, 2026
Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
By Nanobiotix S.A. · Via GlobeNewswire · November 12, 2026
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Completed dose escalation in Phase 1/2 ASCEND trial of CR-001 with more than 125 patients dosed across United States, Europe and South Korea; enrolling standard of care chemotherapy combination expansion cohorts; on track for initial monotherapy data, including antitumor response for first-line non-small cell lung cancer (NSCLC) cohort in Q1 2027
By Crescent Biopharma, Inc. · Via GlobeNewswire · November 12, 2026
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today reported financial results for the fiscal first quarter ended September 30, 2026, and provided a business update.
By AnaptysBio, Inc. · Via GlobeNewswire · November 12, 2026
Royalty Pharma to present at the UBS Global Biopharma Conference
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the UBS Global Biopharma Conference on Tuesday, November 17, 2026 at 5:40 a.m. ET / 10:40 a.m. GMT.
By Royalty Pharma plc · Via GlobeNewswire · November 12, 2026
FinWise Bancorp Announces Increase in Share Repurchase Program
MURRAY, Utah, Nov. 12, 2026 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced that its Board of Directors has authorized an additional 600,000 shares of the Company’s common stock that may be repurchased pursuant to its repurchase program. The program was originally approved by the Board on May 19, 2026, to purchase up to 685,000 shares, or approximately 5% of issued and outstanding shares. As of November 11, 2026, approximately 415,000 shares remained available under the existing authorization. Since the program’s inception, the Company has repurchased 270,000 shares of the Company’s common stock for an aggregate purchase price of $3.7 million. The 600,000 additional shares authorized for the program represent approximately 4.4% of the Company’s outstanding shares of common stock. The repurchases will be made at the Company’s discretion with an expiration of May 31, 2028.
By FinWise Bank · Via GlobeNewswire · November 12, 2026
Energous Wireless Power Solutions Reports Third Quarter 2026 Results
– Third Quarter Revenue Increases 167% Year over Year, Continuing Streak of Consecutive Quarterly Growth– Year-to-Date Revenue Exceeds Full-Year 2025 Results– Conference Call Today at 4:30 p.m. Eastern Time
By Energous · Via GlobeNewswire · November 12, 2026
Unwind by Day, Celebrate by Night: A Holiday Escape on Florida's Historic Coast
Coastal retreats, luxury spas, exceptional dining and St. Augustine's Nights of Lights offer a refreshing way to enjoy the holiday season
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds
IntentKey’s Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds
By Inuvo Inc. · Via GlobeNewswire · November 12, 2026
MILLROSE PROPERTIES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Millrose Properties, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Millrose (MRP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2026
MediaAlpha Announces $16 Million Private Stock Repurchase
LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX), the insurance industry’s leading programmatic customer acquisition platform, today announced that it has repurchased 1.13 million shares of its Class A common stock from an affiliate of White Mountains Insurance Group, Ltd. (NYSE: WTM) for approximately $16.0 million. MediaAlpha bought the shares in a privately negotiated transaction at $14.15 per share, a discount of approximately 5.5% to the closing price of its Class A common stock on November 11, 2026. The repurchased shares will be canceled and retired.
By MediaAlpha, Inc. · Via GlobeNewswire · November 12, 2026
ProKidney Reports Third Quarter 2026 Financial Results and Business Highlights
WINSTON-SALEM, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today reported financial results for the third quarter ended September 30, 2026 and provided business highlights and upcoming milestones.
By ProKidney · Via GlobeNewswire · November 12, 2026
dLocal Reports Third Quarter 2026 Financial Results
TPV reached US$18 billion (+77% year-over-year), marking the 8th consecutive quarter of 50%+ year-over-year growth. Revenue reached US$398 million (+41% year-over-year), with gross profit of US$132 million (+28% year-over-year).Operating profit reached US$76 million (+37% year-over-year), with the Operating Profit/Gross Profit ratio at 58% (+7 p.p. vs. 2Q26), its highest level since 4Q23. Gross profit growth exceeded OPEX growth (+17% year-over-year), reflecting continued cost discipline and automation efforts.Record net income of US$68 million (+31% year-over-year).Adjusted Free Cash Flow reached US$182 million in 9M26, with conversion to net income of 111%, reflecting the reversal of temporary 1Q26 working-capital effects.
By DLocal Limited · Via GlobeNewswire · November 12, 2026
Jushi Holdings Inc. Announces Opening of Relocated Beyond Hello™ Dispensary in Hamburg, Pennsylvania
By Jushi Holdings Inc. · Via GlobeNewswire · November 12, 2026
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Advertising and marketing expense decreases 16.7% sequentially as revenue per dollar of advertising and marketing expense improves approximately 38%
By GAXOS.AI INC. · Via GlobeNewswire · November 12, 2026
Navitas Files Patent Infringement Lawsuit Against Newly Announced Renesas GaN Products
Navitas Takes Swift Legal Action Following Renesas’ Announcement of New REXGaN and 650 V SuperGaN Products
By Navitas Semiconductor Corporation · Via GlobeNewswire · November 12, 2026
Snail, Inc. Reports Third Quarter 2026 Financial Results
CULVER CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced financial results for the third quarter ended September 30, 2026.
By Snail, Inc. · Via GlobeNewswire · November 12, 2026
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
– Completed initial public offering (IPO) and concurrent private placement generating aggregate gross proceeds of approximately $602.5 million; cash position expected to fund operations into 2030 –
By ADARx Pharmaceuticals Inc. · Via GlobeNewswire · November 12, 2026
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027
SAN ANTONIO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported operating revenues of $2.7 million for the quarter ended September 30, 2026, the first quarter of its 2027 fiscal year. That represents an 18% increase over the same quarter a year earlier. The Company posted operating income of $55,000, compared to an operating loss of $515,000 in the September 2025 quarter, as operating expenses declined 6% year-over-year. Net income for the quarter was $171,000, or $0.01 per share, compared to $1.5 million, or $0.12 per share, a year earlier. The difference was driven primarily by lower investment income.
By U.S. Global Investors · Via GlobeNewswire · November 12, 2026
LOBO TECHNOLOGIES LTD. Announces Share Consolidation
WUXI, China, Nov. 12, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative manufacturer of electric mobility products and AI service provider, today announced that it will effect a share consolidation of its Class A ordinary shares, par value $0.001 per share, and Class B ordinary shares, par value $0.001 per share, at a ratio of 1-for-10, effective on November 17, 2026 (the “Share Consolidation”). The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on November 17, 2026. Upon the market opening on November 17, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “LOBO” with the new CUSIP number G00350127.
By LOBO EV TECHNOLOGIES LTD. · Via GlobeNewswire · November 12, 2026
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially
Proposed TYTL Acquisition Expected to Finalize Definitive Agreements Within Days Positioning Beeline as a Leader in AI-Powered, Blockchain-Enabled Real Estate Finance
By Beeline Holdings Inc. · Via GlobeNewswire · November 12, 2026
Park Dental Partners Announces Third Quarter 2026 Results
MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables.
By Park Dental Partners · Via GlobeNewswire · November 12, 2026
Merlin, Inc. Reports Third Quarter 2026 Results
Ended Third Quarter 2026 With $161.6 Million in Cash, Cash Equivalents, and Short Term Investments, and No Debt
By Merlin Labs, Inc. · Via GlobeNewswire · November 12, 2026
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
REMAIN-1 Pivotal Cohort met its six-month co-primary endpoint with high statistical significance (p=0.0023); Revita® participants retained approximately 80% of GLP-1-induced weight loss versus 67% for sham
By Fractyl Health, Inc. · Via GlobeNewswire · November 12, 2026
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
-- Zola® Q3 revenues increase 24% year-over-year, largest quarterly sales ever ---- New 1L espresso formulation ships this month, slim cans to launch in early 2027 --
By Arcadia Biosciences, Inc. · Via GlobeNewswire · November 12, 2026
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings Growth of over 350%, and Robust Cash Generation
Third Quarter 2026 Business Highlights
By Accelevation · Via GlobeNewswire · November 12, 2026
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability
Product revenue grew 24% to $5.7 million, driven by strong software licensing performance; gross margin reached 90% for the second consecutive quarter
By ROC · Via GlobeNewswire · November 12, 2026
nCino Announces Timing of its Third Quarter Fiscal Year 2027 Financial Results Conference Call
WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, will report financial results for its third quarter ended October 31, 2026, after the market close on Tuesday, December 1, 2026. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results.
By nCino, Inc. · Via GlobeNewswire · November 12, 2026
Streamex Reports Third Quarter 2026 Results
240 net new ounces behind GLDY, up from 15 in Q2; Cask Foundation begins liquidity bootstrapping for USGY; debt-free with $36.5 million total liquidity position(1)
By Streamex Corp. · Via GlobeNewswire · November 12, 2026
Cibus Reports Third Quarter Financial Results and Provides Business Update
Rice herbicide-tolerance traits performed well in Latin American field trials and are now being tested by customer Interoc in its own varieties
By Cibus US LLC · Via GlobeNewswire · November 12, 2026
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) (the “Company” or “Fluent”), a commerce media solutions provider, today reported unaudited financial results for the third quarter ended September 30, 2026.
By Fluent, Inc. · Via GlobeNewswire · November 12, 2026
OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Company
Q3 Marked Pivotal Shift to High-Margin RWA Platform and Major Deal Origination Business
By OpenWorld, Inc. · Via GlobeNewswire · November 12, 2026
Articles from GlobeNewswire | WAOW